Deutsche Bank Ag\ Angion Biomedica Corp. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.1 - $2.23 $14,840 - $30,084	-13,491 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.72 - $2.96 $2,404 - $4,138	-1,398 Reduced 9.39%	13,491 $29,000
Q4 2021 Feb 11, 2022	BUY	$2.35 - $9.95 $1,762 - $7,462	750 Added 5.3%	14,889 $43,000
Q3 2021 Nov 04, 2021	BUY	$9.31 - $13.25 $98,611 - $140,344	10,592 Added 298.62%	14,139 $138,000
Q2 2021 Aug 11, 2021	SELL	$13.02 - $17.83 $1,445 - $1,979	-111 Reduced 3.03%	3,547 $46,000

Q1 2021 May 13, 2021	BUY	$15.01 - $25.74 $54,906 - $94,156	3,658 New	3,658 $66,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.